|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang Z, Zheng Y, Wen W, Wu C, Bao P, Wang
C, Zhong W, Gao YT, Jin F, Xiang YB, et al: Incidence and mortality
of gynaecological cancers: Secular trends in urban Shanghai, China
over 40 years. Eur J Cancer. 63:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Høgdall E: Approaches to the detection of
ovarian cancer. Scand J Clin Lab Invest Suppl. 245:S49–S53. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Winter WE III, Maxwell GL, Tian C, Carlson
JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F and
McGuire WP; Gynecologic Oncology Group Study, : Prognostic factors
for stage III epithelial ovarian cancer: A gynecologic oncology
group study. J Clin Oncol. 25:3621–3627. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chi DS, Eisenhauer EL, Lang J, Huh J,
Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M and Barakat
RR: What is the optimal goal of primary cytoreductive surgery for
bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol.
103:559–564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bristow RE, Tomacruz RS, Armstrong DK,
Trimble EL and Montz FJ: Survival effect of maximal cytoreductive
surgery for advanced ovarian carcinoma during the platinum era: A
meta-analysis. J Clin Oncol. 20:1248–1259. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kehoe SM, Eisenhauer EL and Chi DS: Upper
abdominal surgical procedures: Liver mobilization and diaphragm
peritonectomy/resection, splenectomy, and distal pancreatectomy.
Gynecol Oncol. 111 (Suppl 2):S51–S55. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eisenhauer EL, Abu-Rustum NR, Sonoda Y,
Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP,
D'Angelica MI, Barakat RR and Chi DS: The addition of extensive
upper abdominal surgery to achieve optimal cytoreduction improves
survival in patients with stages IIIC-IV epithelial ovarian cancer.
Gynecol Oncol. 103:1083–1090. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hynninen J, Lavonius M, Oksa S, Grénman S,
Carpén O and Auranen A: Is perioperative visual estimation of
intra-abdominal tumor spread reliable in ovarian cancer surgery
after neoadjuvant chemotherapy? Gynecol Oncol. 128:229–232. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv X, Cui S, Zhang X and Ren C: Efficacy
and safety of neoadjuvant chemotherapy versus primary debulking
surgery in patients with ovarian cancer: A meta-analysis. J Gynecol
Oncol. 31:e122020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siesto G, Cavina R, Romano F and Vitobello
D: Primary debulking surgery versus neoadjuvant chemotherapy in
advanced epithelial ovarian cancer: A propensity-matched analysis.
Am J Clin Oncol. 41:280–285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen M, Chen Z, Xu M, Liu D, Liu T, He M
and Yao S: Impact of the time interval from neoadjuvant
chemotherapy to surgery in primary ovarian, tubal, and peritoneal
cancer patients. J Cancer. 9:4087–4091. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cole AL, Barber EL, Gogate A, Tran AQ and
Wheeler SB: Economic analysis of neoadjuvant chemotherapy versus
primary debulking surgery for advanced epithelial ovarian cancer
using an aggressive surgical paradigm. Int J Gynecol Cancer.
28:1077–1084. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eisenkop SM, Spirtos NM, Friedman RL, Lin
W-CM, Pisani AL and Perticucci S: Relative influences of tumor
volume before surgery and the cytoreductive outcome on survival for
patients with advanced ovarian cancer: A prospective study. Gynecol
Oncol. 90:390–396. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aletti GD, Dowdy SC, Gostout BS, Jones MB,
Stanhope CR, Wilson TO, Podratz KC and Cliby WA: Aggressive
surgical effort and improved survival in advanced-stage ovarian
cancer. Obstet Gynecol. 107:77–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chi DS, Zivanovic O, Levinson KL, Kolev V,
Huh J, Dottino J, Gardner GJ, Leitao MM Jr, Levine DA, Sonoda Y, et
al: The incidence of major complications after the performance of
extensive upper abdominal surgical procedures during primary
cytoreduction of advanced ovarian, tubal, and peritoneal
carcinomas. Gynecol Oncol. 119:38–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benedetti Panici P, Di Donato V, Fischetti
M, Casorelli A, Perniola G, Musella A, Marchetti C, Palaia I,
Berloco P and Muzii L: Predictors of postoperative morbidity after
cytoreduction for advanced ovarian cancer: Analysis and management
of complications in upper abdominal surgery. Gynecol Oncol.
137:406–411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tozzi R, Casarin J, Garruto-Campanile R,
Majd HS and Morotti M: Morbidity and reversal rate of ileostomy
after bowel resection during visceral-peritoneal debulking (VPD) in
patients with stage IIIC-IV ovarian cancer. Gynecol Oncol.
148:74–78. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Phillips A, Sundar S, Singh K, Pounds R,
Nevin J, Kehoe S, Balega J and Elattar A: The NICE classification
for ‘Ultra-radical (extensive) surgery for advanced ovarian cancer’
guidance does not meaningfully predict postoperative complications:
A cohort study. BJOG. 126:96–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Prat J; FIGO Committee on Gynecologic
Oncology, : FIGO's staging classification for cancer of the ovary,
fallopian tube, and peritoneum: Abridged republication. J Gynecol
Oncol. 26:87–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Y: Overweight and obesity in China.
BMJ. 333:362–363. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Querleu D, Planchamp F, Chiva L,
Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg
C, Davidson B, et al: European society of gynaecological oncology
(ESGO) guidelines for ovarian cancer surgery. Int J Gynecol Cancer.
27:1534–1542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nelson G, Altman AD, Nick A, Meyer LA,
Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, et al:
Guidelines for pre- and intra-operative care in
gynecologic/oncology surgery: Enhanced recovery after surgery
(ERAS®) society recommendations-part I. Gynecol Oncol.
140:313–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nelson G, Altman AD, Nick A, Meyer LA,
Ramirez PT, Achtari C, Antrobus J, Huang J, Scott M, Wijk L, et al:
Guidelines for postoperative care in gynecologic/oncology surgery:
Enhanced recovery after surgery (ERAS®) society
recommendations-part II. Gynecol Oncol. 140:323–332. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tozzi R, Gubbala K, Majd HS and Campanile
RG: Interval laparoscopic en-bloc resection of the pelvis (L-EnBRP)
in patients with stage IIIC-IV ovarian cancer: Description of the
technique and surgical outcomes. Gynecol Oncol. 142:477–483. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tozzi R, Hardern K, Gubbala K, Garruto
Campanile R and Soleymani Majd H: En-bloc resection of the pelvis
(EnBRP) in patients with stage IIIC-IV ovarian cancer: A 10 steps
standardised technique. Surgical and survival outcomes of primary
vs interval surgery. Gynecol Oncol. 144:564–570. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aletti GD, Dowdy SC, Podratz KC and Cliby
WA: Relationship among surgical complexity, short-term morbidity,
and overall survival in primary surgery for advanced ovarian
cancer. Am J Obstet Gynecol. 197:676.e1–e7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Strasberg SM, Linehan DC and Hawkins WG:
The accordion severity grading system of surgical complications.
Ann Surg. 250:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soleymani Majd H, Ferrari F, Manek S,
Gubbala K, Campanile RG, Hardern K and Tozzi R: Diaphragmatic
peritonectomy vs full thickness resection with pleurectomy during
visceral-peritoneal debulking (VPD) in 100 consecutive patients
with stage IIIC-IV ovarian cancer: A surgical-histological
analysis. Gynecol Oncol. 140:430–435. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rahbari NN, Weitz J, Hohenberger W, Heald
RJ, Moran B, Ulrich A, Holm T, Wong WD, Tiret E, Moriya Y, et al:
Definition and grading of anastomotic leakage following anterior
resection of the rectum: A proposal by the international study
group of rectal cancer. Surgery. 147:339–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gessler B, Eriksson O and Angenete E:
Diagnosis, treatment, and consequences of anastomotic leakage in
colorectal surgery. Int J Colorectal Dis. 32:549–556. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bassi C, Marchegiani G, Dervenis C, Sarr
M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink
MG, et al: The 2016 update of the international study group (ISGPS)
definition and grading of postoperative pancreatic fistula: 11
Years after. Surgery. 161:584–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Feldheiser A, Aziz O, Baldini G, Cox BP,
Fearon KC, Feldman LS, Gan TJ, Kennedy RH, Ljungqvist O, Lobo DN,
et al: Enhanced recovery after surgery (ERAS) for gastrointestinal
surgery, part 2: Consensus statement for anaesthesia practice. Acta
Anaesthesiol Scand. 60:289–334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Scott MJ, Baldini G, Fearon KC, Feldheiser
A, Feldman LS, Gan TJ, Ljungqvist O, Lobo DN, Rockall TA, Schricker
T and Carli F: Enhanced recovery after surgery (ERAS) for
gastrointestinal surgery, part 1: Pathophysiological
considerations. Acta Anaesthesiol Scand. 59:1212–1231. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Labgaa I, Joliat GR, Kefleyesus A,
Mantziari S, Schäfer M, Demartines N and Hübner M: Is postoperative
decrease of serum albumin an early predictor of complications after
major abdominal surgery? A prospective cohort study in a European
centre. BMJ Open. 7:e0139662017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bisch S, Nelson G and Altman A: Impact of
nutrition on enhanced recovery after surgery (ERAS) in gynecologic
oncology. Nutrients. 11:10882019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barber EL, Boggess JF, Van Le L, Kim KH,
Bae-Jump VL, Brewster WR, Soper JT and Gehrig PA: Association of
preoperative thrombocytosis and leukocytosis with postoperative
morbidity and mortality among patients with ovarian cancer. Obstet
Gynecol. 126:1191–1197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lomnytska M, Karlsson E, Jonsdottir B,
Lejon AM, Stålberg K, Poromaa IS, Silins I and Graf W: Peritoneal
cancer index predicts severe complications after ovarian cancer
surgery. Eur J Surg Oncol. 47:2915–2924. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cham S, Chen L, St Clair CM, Hou JY,
Tergas AI, Melamed A, Ananth CV, Neugut AI, Hershman DL and Wright
JD: Development and validation of a risk-calculator for adverse
perioperative outcomes for women with ovarian cancer. Am J Obstet
Gynecol. 220:571.e1–571.e8. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ataseven B, du Bois A, Reinthaller A,
Traut A, Heitz F, Aust S, Prader S, Polterauer S, Harter P and
Grimm C: Pre-operative serum albumin is associated with
post-operative complication rate and overall survival in patients
with epithelial ovarian cancer undergoing cytoreductive surgery.
Gynecol Oncol. 138:560–565. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ge LN and Wang F: Prognostic significance
of preoperative serum albumin in epithelial ovarian cancer
patients: A systematic review and dose-response meta-analysis of
observational studies. Cancer Manag Res. 10:815–825. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ayhan A, Günakan E, Alyazıcı İ, Haberal N,
Altundağ Ö and Dursun P: The preoperative albumin level is an
independent prognostic factor for optimally debulked epithelial
ovarian cancer. Arch Gynecol Obstet. 296:989–995. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Asher V, Lee J and Bali A: Preoperative
serum albumin is an independent prognostic predictor of survival in
ovarian cancer. Med Oncol. 29:2005–2009. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Coosemans AN, Baert T, D'Heygere V,
Wouters R, DE Laet L, VAN Hoylandt A, Thirion G, Ceusters J, Laenen
A, Vandecaveye V and Vergote I: Increased immunosuppression is
related to increased amounts of ascites and inferior prognosis in
ovarian cancer. Anticancer Res. 39:5953–5962. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Szender JB, Emmons T, Belliotti S, Dickson
D, Khan A, Morrell K, Khan ANMN, Singel KL, Mayor PC, Moysich KB,
et al: Impact of ascites volume on clinical outcomes in ovarian
cancer: A cohort study. Gynecol Oncol. 146:491–497. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Günakan E, Tohma YA, Tunç M, Akıllı H,
Şahin H and Ayhan A: Factors associated with surgical morbidity of
primary debulking in epithelial ovarian cancer. Obstet Gynecol Sci.
63:64–71. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bartl T, Schwameis R, Stift A,
Bachleitner-Hofmann T, Reinthaller A, Grimm C and Polterauer S:
Predictive and prognostic implication of bowel resections during
primary cytoreductive surgery in advanced epithelial ovarian
cancer. Int J Gynecol Cancer. 28:1664–1671. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Charnley RM: Effect of specialist
decision-making on treatment strategies for colorectal liver
metastases. Br J Surg. 2012.99:1263–1269. Br J Surg. 99:1269–1270.
2012. View Article : Google Scholar
|
|
50
|
Eng OS, Raoof M, Blakely AM, Yu X, Lee SJ,
Han ES, Wakabayashi MT, Yuh B, Lee B and Dellinger TH: A
collaborative surgical approach to upper and lower abdominal
cytoreductive surgery in ovarian cancer. J Surg Oncol. 118:121–126.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jones RP, Vauthey JN, Adam R, Rees M,
Berry D, Jackson R, Grimes N, Fenwick SW, Poston GJ and Malik HZ:
Effect of specialist decision-making on treatment strategies for
colorectal liver metastases. Br J Surg. 99:1263–1269. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Aletti GD, Long HJ, Podratz KC and Cliby
WA: Is time to chemotherapy a determinant of prognosis in
advanced-stage ovarian cancer? Gynecol Oncol. 104:212–216. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Timmermans M, van der Aa MA, Lalisang RI,
Witteveen PO, Van de Vijver KK, Kruitwagen RF and Sonke GS:
Interval between debulking surgery and adjuvant chemotherapy is
associated with overall survival in patients with advanced ovarian
cancer. Gynecol Oncol. 150:446–450. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Alexander M, Beattie-Manning R, Blum R,
Byrne J, Hornby C, Kearny C, Love N, McGlashan J, McKiernan S,
Milar JL, et al: Guidelines for timely initiation of chemotherapy:
A proposed framework for access to medical oncology and haematology
cancer clinics and chemotherapy services. Intern Med J. 46:964–969.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wijk L, Udumyan R, Pache B, Altman AD,
Williams LL, Elias KM, McGee J, Wells T, Gramlich L, Holcomb K, et
al: International validation of enhanced recovery after surgery
society guidelines on enhanced recovery for gynecologic surgery. Am
J Obstet Gynecol. 221:237.e1–237.e11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kay AH, Venn M, Urban R, Gray HJ and Goff
B: Postoperative narcotic use in patients with ovarian cancer on an
enhanced recovery after surgery (ERAS) pathway. Gynecol Oncol.
156:624–628. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Dowdy SC: Enhanced recovery after surgery
for ovarian cancer. Clin Adv Hematol Oncol. 17:217–219.
2019.PubMed/NCBI
|
|
58
|
Damania R and Cocieru A: Impact of
enhanced recovery after surgery protocols on postoperative
morbidity and mortality in patients undergoing routine hepatectomy:
Review of the current evidence. Ann Transl Med. 5:3412017.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Nelson G, Bakkum-Gamez J, Kalogera E,
Glaser G, Altman A, Meyer LA, Taylor JS, Iniesta M, Lasala J, Mena
G, et al: Guidelines for perioperative care in
gynecologic/oncology: Enhanced recovery after surgery (ERAS)
society recommendations-2019 update. Int J Gynecol Cancer.
29:651–668. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Lindemann K, Kok PS, Stockler M, Jaaback K
and Brand A: Enhanced recovery after surgery for advanced ovarian
cancer: A systematic review of interventions trialed. Int J Gynecol
Cancer. 27:1274–1282. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Goulet D, Danilack V and Matteson KA:
Enhanced recovery pathways for improving outcomes after minimally
invasive gynecologic oncology surgery. Obstet Gynecol. 129:2072017.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Chapman JS, Roddy E, Ueda S, Brooks R,
Chen LL and Chen LM: Enhanced recovery pathways for improving
outcomes after minimally invasive gynecologic oncology surgery.
Obstet Gynecol. 128:138–144. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Carter J: Enhanced recovery in gynecologic
surgery. Obstet Gynecol. 122:13052013. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kalogera E, Bakkum-Gamez JN, Jankowski CJ,
Trabuco E, Lovely JK, Dhanorker S, Grubbs PL, Weaver AL, Haas LR,
Borah BJ, et al: Enhanced recovery in gynecologic surgery. Obstet
Gynecol. 122:319–328. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Rosa DD, Clamp A, Mullamitha S, Ton NC,
Lau S, Byrd L, Clayton R, Slade RJ, Kitchener HC, Shanks JH, et al:
The interval from surgery to chemotherapy in the treatment of
advanced epithelial ovarian carcinoma. Eur J Surg Oncol.
32:588–591. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cliby W, Dowdy S, Feitoza SS, Gostout BS
and Podratz KC: Diaphragm resection for ovarian cancer: Technique
and short-term complications. Gynecol Oncol. 94:655–660. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ye S, He T, Liang S, Chen X, Wu X, Yang H
and Xiang L: Diaphragmatic surgery and related complications in
primary cytoreduction for advanced ovarian, tubal, and peritoneal
carcinoma. BMC Cancer. 17:3172017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Filippa N, Carricajo A, Grattard F, Fascia
P, El Sayed F, Defilippis JP, Berthelot P and Aubert G: Outbreak of
multidrug-resistant Klebsiella pneumoniae carrying qnrB1 and
blaCTX-M15 in a French intensive care unit. Ann Intensive Care.
3:182013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Rao SSC, Tan G, Abdulla H, Yu S, Larion S
and Leelasinjaroen P: Does colectomy predispose to small intestinal
bacterial (SIBO) and fungal overgrowth (SIFO)? Clin Transl
Gastroenterol. 9:1462018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Shichinohe T, Sasaki T, Kitashiro S,
Morita T, Ono K, Senmaru N, Ikeda J, Kojima T, Kyogoku N, Yamada H,
et al: Impact of elemental diet on early recovery after
laparoscopic colectomy: Findings of a randomized controlled trial.
Surg Today. 47:166–173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Garcia-Granero A, Frasson M, Flor-Lorente
B, Blanco F, Puga R, Carratalá A and Garcia-Granero E:
Procalcitonin and C-reactive protein as early predictors of
anastomotic leak in colorectal surgery: A prospective observational
study. Dis Colon Rectum. 56:475–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Son JH, Kong TW, Paek J, Chang SJ and Ryu
HS: Perioperative outcomes of extensive bowel resection during
cytoreductive surgery in patients with advanced ovarian cancer. J
Surg Oncol. 119:1011–1015. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Spetzler VN, Schepers M, Pinnschmidt HO,
Fischer L, Nashan B and Li J: The incidence and severity of
post-hepatectomy bile leaks is affected by surgical indications,
preoperative chemotherapy, and surgical procedures. Hepatobiliary
Surg Nutr. 8:101–110. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Nashan B and Citterio F: Wound healing
complications and the use of mammalian target of rapamycin
inhibitors in kidney transplantation: A critical review of the
literature. Transplantation. 94:547–561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sánchez-Iglesias JL, Gómez-Hidalgo NR,
Pérez-Benavente A, Carbonell-Socias M, Manrique-Muñoz S, Serrano
MP, Gutiérrez-Barceló P, Bradbury M, Nelson G and Gil-Moreno A:
Importance of enhanced recovery after surgery (ERAS) protocol
compliance for length of stay in ovarian cancer surgery. Ann Surg
Oncol. 28:8979–8986. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Reuter S, Woelber L, Trepte CC, Perez D,
Zapf A, Cevirme S, Mueller V, Schmalfeldt B and Jaeger A: The
impact of enhanced recovery after surgery (ERAS) pathways with
regard to perioperative outcome in patients with ovarian cancer.
Arch Gynecol Obstet. Dec 27–2021.(Epub ahead of print). View Article : Google Scholar
|
|
77
|
Agarwal R, Rajanbabu A, Nitu PV, Goel G,
Madhusudanan L and Unnikrishnan UG: A prospective study evaluating
the impact of implementing the ERAS protocol on patients undergoing
surgery for advanced ovarian cancer. Int J Gynecol Cancer.
29:605–612. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Meyer LA, Shi Q, Lasala J, Iniesta MD, Lin
HK, Nick AM, Williams L, Sun C, Wang XS, Lu KH and Ramirez PT:
Comparison of patient reported symptom burden on an enhanced
recovery after surgery (ERAS) care pathway in patients with ovarian
cancer undergoing primary vs interval tumor reductive surgery.
Gynecol Oncol. 152:501–508. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Tankou JI, Foley O, Falzone M,
Kalyanaraman R and Elias KM: Enhanced recovery after surgery
protocols improve time to return to intended oncology treatment
following interval cytoreductive surgery for advanced gynecologic
cancers. Int J Gynecol Cancer. 31:1145–1153. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Duzgun O: Evaluation of enhanced recovery
after following a surgical protocol for cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy for peritoneal
carcinomatosis. Med Arch. 73:331–337. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Noh JJ, Kim MS and Lee YY: The
implementation of enhanced recovery after surgery protocols in
ovarian malignancy surgery. Gland Surg. 10:1182–1194. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Sánchez-Iglesias JL, Carbonell-Socias M,
Pérez-Benavente MA, Monreal Clua S, Manrique-Muñoz S, García Gorriz
M, Burgos-Peláez R, Segurola Gurrutxaga H, Pamies Serrano M, Pilar
Gutiérrez-Barceló MD, et al: PROFAST: A randomised trial
implementing enhanced recovery after surgery for highcomplexity
advanced ovarian cancer surgery. Eur J Cancer. 136:149–158. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Bisch SP, Kooy J, Glaze S, Cameron A, Chu
P, Ghatage P, Nation J, Nelson G and Fitzmaurice GM: Impact of
transversus abdominis plane blocks versus non-steroidal
anti-inflammatory on post-operative opioid use in ERAS ovarian
cancer surgery. Int J Gynecol Cancer. 29:1372–1376. 2019.
View Article : Google Scholar : PubMed/NCBI
|
